BioBoston Consulting

How to Audit for 21 CFR Part 11 Compliance in Digital Systems

Compliance ensures that your digital systems are secure, reliable, and audit-ready for FDA and EMA inspections.

Your One Stop Solution for Life Sciences In the biopharma and biotech industries, ensuring 21 CFR Part 11 compliance in digital systems is essential for regulatory compliance, data integrity, and audit readiness. Digital systems such as LIMS, ERP, MES, and electronic laboratory notebooks (ELN) must meet FDA requirements for electronic records and electronic signatures. BioBoston […]